K03861 is a type II CDK2 inhibitor with Kd of 8.2 nM.
K03861 inhibits CDK2 activity by competing with binding of activating cyclins.
For research use only. We do not sell to patients.
| Name | K03861 |
|---|---|
| Iupac Chemical Name | K03861 |
| Synonyms | K 03861; K-03861 |
| Molecular Formula | C24H26F3N7O2 |
| Molecular Weight | 501.5 |
| Smile | CN1CCN(CC1)Cc2ccc(cc2C(F)(F)F)NC(=O)Nc3ccc(cc3)Oc4ccnc(n4)N |
| InChiKey | PWDLXPJQFNVTNL-UHFFFAOYSA-N |
| InChi | InChI=1S/C24H26F3N7O2/c1-33-10-12-34(13-11-33)15-16-2-3-18(14-20(16)24(25,26)27)31-23(35)30-17-4-6-19(7-5-17)36-21-8-9-29-22(28)32-21/h2-9,14H,10-13,15H2,1H3,(H2,28,29,32)(H2,30,31,35) |
| CAS Number | 853299-07-7 |
| MDL | MFCD19443769 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | crystalline solid |
|---|---|
| Purity | 98% |
| Storage | 3 years -20ºCpowder |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |